Open AccessDiscovery of potential visfatin activators using in silico docking and ADME predictions as therapy for type 2 diabetes
Author(s) -
Olusola Olalekan Elekofehinti,
Oluwamodupe Cecilia Ejelonu,
Jean Paul Kamdem,
Oluwaseun Benedicta Akinlosotu,
Ayodeji Famuti,
Damilare Desmond Adebowale,
Opeyemi Iwaloye,
Yetunde Irinyemi Bulu,
Ige Joseph Kade,
João Batista Teixeira da Rocha
Publication year - 2018
Publication title -
beni-seuf university journal of basic and applied sciences /beni-suef university journal of basic and applied sciences
Language(s) - English
Resource type - Journals
eISSN - 2314-8543
pISSN - 2314-8535
DOI - 10.1016/j.bjbas.2018.02.007
Subject(s) - adme , nicotinamide phosphoribosyltransferase , chemistry , pharmacology , protein data bank (rcsb pdb) , druggability , peroxisome proliferator activated receptor , rosiglitazone , docking (animal) , lipinski's rule of five , in silico , chembl , biochemistry , receptor , medicine , drug discovery , enzyme , in vitro , nad+ kinase , nursing , gene